Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Oct;4(10 Pt 1):844-9.
doi: 10.1093/ajh/4.10.844.

White coat phenomenon in patients receiving antihypertensive therapy

Affiliations

White coat phenomenon in patients receiving antihypertensive therapy

M G Myers et al. Am J Hypertens. 1991 Oct.

Abstract

The occurrence of the white coat phenomenon in hypertensive patients receiving drug therapy was determined in a consecutive series of 71 patients undergoing ambulatory blood pressure (ABP) recordings because of suspected differences between office and ambulatory values. Overall mean (+/- SEM) office blood pressure (BP) was 166 +/- 2/95 +/- 1 v awake ABP 139 +/- 2/86 +/- 1 mm Hg. The white coat phenomenon [(office BP - ABP) greater than or equal to 20/10 mm Hg] was present in 52 of 71 patients: office BP 170 +/- 3/96 +/- 2 v ABP 135 +/- 2/83 +/- 1 mm Hg. A marked white coat effect [(office BP - ABP) greater than or equal to 40/20 mm Hg] was seen in 22 patients with office BP being 178 +/- 4/98 +/- 3 v ABP 131 +/- 3/79 +/- 2 mm Hg. The frequent occurrence of white coat phenomenon in these patients suggests that office BP readings may not always represent usual ABP in patients receiving chronic antihypertensive therapy.

PubMed Disclaimer

Publication types

Substances